Jiawei Zheng | Toxicology | Excellence in Research Award

Published on by Cognitive Scientist Awards

Mr. Jiawei Zheng | Toxicology | Excellence in Research Award 

Jinquan Satellite Launch Center Hospital | China

Jiawei Zheng is an attending doctor at the Jiuquan Satellite Launch Center Hospital whose work integrates clinical practice with specialized research in occupational toxicology, particularly focusing on hepatotoxicity mechanisms relevant to aerospace environments. Trained in medical sciences with a concentration in toxicology, he has built a career that blends laboratory investigation with applied aerospace-medicine service, serving as a principal investigator for internally supported projects aimed at understanding and mitigating toxin-induced organ injury. His research explores oxidative stress, apoptosis signaling, and metabolic intervention, with special emphasis on the pathways disrupted by exposure to aerospace-related chemicals. He has developed strong skills in experimental design, animal modeling, cellular and biochemical analysis, mechanistic interpretation, and scientific writing, demonstrated through his first-author contribution to a peer-reviewed article that reveals a novel mechanistic pathway underlying UDMH-induced liver injury. His professional experience also includes leading a hospital consultancy initiative focused on toxicological risk assessment. Although early in his publication journey, his work has already contributed meaningful insights to the field of hepatotoxicity research. With dedication to advancing occupational health protection for aerospace personnel, he continues to pursue research that supports scientific innovation, clinical safety, and the broader mission of improving health resilience in high-risk technological environments.

Profile: ORCID

Featured Publications

Zheng, J., Liu, W., Zhu, X., Ran, L., Lang, H., Yi, L., Mi, M., & Zhu, J. (2020). Pterostilbene enhances endurance capacity via promoting skeletal muscle adaptations to exercise training in rats. Molecules, 25(1), 186.

Huang, Y., Zhu, X., Chen, K., Lang, H., Zhang, Y., Hou, P., Ran, L., Zhou, M., Zheng, J., Yi, L., & Mi, M. (2019). Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway. Aging (Albany NY), 11(8), 2217–2240.

 

Elif Baris | Pharmacology | Excellence in Research Award

Published on by Cognitive Scientist Awards

Assoc. Prof. Dr. Elif Baris | Pharmacology | Excellence in Research Award

İzmir University of Economics | Turkey

Elif Baris is an Assistant Professor of Medical Pharmacology at Izmir University of Economics, specializing in molecular pharmacology with a strong focus on inflammation, pain physiology, and cholinergic anti-inflammatory mechanisms. She holds a pharmacy degree and a doctoral qualification in medical pharmacology from Dokuz Eylül University, and has developed expertise in cytokine signaling, oxidative stress, neuroimmune modulation, molecular oncology, stem cell immunoregulation, and sepsis models. Her professional experience includes leading and contributing to numerous multidisciplinary research projects supported by national and institutional scientific bodies, alongside collaborations with prominent medical and biotechnology institutions. Her research interests extend to autonomic nervous system pharmacology, neuroimmune interactions, mechanotransduction through TRPV4 channels, and innovative drug repurposing strategies. She possesses strong research skills in qRT-PCR, Western blotting, ELISA, cytokine arrays, flow cytometry, and real-time cell analysis, supported by extensive publications in indexed journals and multiple patents involving varenicline- and choline-based therapeutic applications. She has received recognition through collaborative roles in funded research, chapter authorship in academic publications, and contributions to translational pharmacology. Her professional memberships include national societies in pharmacology and physiology, reflecting her commitment to scientific advancement. With her growing contributions to drug innovation, inflammation therapeutics, and molecular pharmacology, she continues to advance impactful research aimed at improving mechanisms of pain management and immune regulation.

Profile: Google scholar

Featured Publications

Baris, E., Efe, H., Gumustekin, M., Arici, M. A., & Tosun, M. (2021). Varenicline prevents LPS-induced inflammatory response via nicotinic acetylcholine receptors in RAW 264.7 macrophages. Frontiers in Molecular Biosciences, 8, 721533. [15 citations]

Baris, E., Simsek, O., Arici, M. A., & Tosun, M. (2023). Choline and citicoline ameliorate oxidative stress in acute kidney injury in rats. Bratislava Medical Journal / Bratislavské Lekárske Listy, 124(1). [12 citations]

Baris, E., Simsek, O., Efe, H., Oncu, S., Gelal, A., Hamurtekin, E., Tosun, M., … (2021). Effects of CDP-choline and choline on COX pathway in LPS-induced inflammatory response in rats. International Journal of Pharmacology, 17(2), 84–96. [10 citations]

Baris, E., Arici, M. A., & Tosun, M. (2024). Nicotinic acetylcholine receptor-mediated effects of varenicline on LPS-elevated prostaglandin and cyclooxygenase levels in RAW 264.7 macrophages. Frontiers in Molecular Biosciences, 11, 1392689. [4 citations]